Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Genentech’s Ocrelizumab Wows in Late Stages and Eyes $18 Billion MS Market

South San Francisco, Calif.-based Genentech (RHHBY) announced today that its clinical studies of ocrelizumab compared to interferon beta-1a (Rebif) in relapsing multiple sclerosis (MS) met their primary and major secondary endpoints.   Two Phase III studies are being conducted, OPERA I and OPERA II. The primary endpoint of both studies was annualized protocol-defined relapse rate […]

Read More »

California governor signs bill limiting school vaccine exemptions

California Governor Jerry Brown on Tuesday signed a bill eliminating the state’s personal beliefs exemption for school vaccine requirements – legislation that was prompted by a measles outbreak at Disneyland linked to low vaccination rates. The new law, which makes California only the third state to eliminate religious and other personal vaccine exemptions, generated vociferous […]

Read More »

Cuba named first country to end mother-to-child HIV transmission

The World Health Organization on Tuesday declared Cuba the first country in the world to eliminate the transmission of HIV and syphilis from mother to child. The WHO said in a statement that an international delegation that it and the Pan American Health Organization sent to Cuba in March determined the country met the criteria […]

Read More »

Beware of animal diseases as biological weapons, health experts say

The World Health Organization, animal health and national defense officers called on Tuesday for wider international cooperation to avoid the spread of animal diseases that could be used as biological weapons. Sixty percent of human diseases come from animal agents and 80 percent of the agents that could be used for bio terrorism are of […]

Read More »

Sugary Drinks Linked To Many Thousands Of Deaths Globally

More morbid news for sugar: Researchers calculate that sugary drinks alone are responsible for many thousands of deaths per year. And this adds to an increasing shift in the nutritional tide. Dietary fat – which was once the biggest culprit – is now getting a reprieve, as the upper limit on fat intake has just been scrapped in […]

Read More »

New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State

SACRAMENTO, Calif., June 30, 2015 /PRNewswire/ — A new analysis and infographic released today estimate California’s exposure to high-priced Hepatitis C medications could range from hundreds of millions of dollars, even if only 5 percent of Californians infected with Hepatitis C receive treatment through state programs. The analysis, which looks at the costly impact of […]

Read More »

Eolas Therapeutics and AstraZeneca Partner to Develop Orexin-1 Receptor Antagonist for Multiple Indications

CARLSBAD, Calif., June 30, 2015 /PRNewswire/ — Eolas Therapeutics, Inc. announced today that is has entered into a worldwide license and partnership agreement with AstraZeneca on the Eolas Orexin-1 Receptor Antagonist (EORA) program for smoking cessation and other indications. The EORA program was awarded a Blueprint Neurotherapeutics (BPN) grant from the National Institutes of Health (NIH) […]

Read More »

Novartis to test new pricing model with heart failure drug

Novartis plans to test a novel pricing model with some customers when it launches its keenly awaited new heart failure drug Entresto, the Swiss company’s head of pharmaceuticals said on Tuesday. Entresto, also known as LCZ696, is the first new drug in decades for helping patients whose lives are in danger because their hearts cannot […]

Read More »

Did Celgene’s Billion Dollar Deal With Juno Just Save The Biotech Bull Market?

Just when you think a biotech bear market is about to descend, the bulls come rushing in. News of a Greek default depressed markets yesterday and was only compounded by fears of a potential default by Puerto Rico.  Many of the large fund systems that are invested in too-good-to-be-true Puerto Rican bonds are also invested in […]

Read More »

Korean Healthtech Startup Closing In On Cure For Alzheimer’s

Korea’s startup landscape remains partial to gaming. Demand has been growing at such a staggering clip that the industry now accounts for 90% of the country’s mobile app revenues. The government is also providing financial assistance — to the tune of $90 million — to help shoulder rising demand. But though many welcome such incentives, the figures […]

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

February 2019 Focus: Agenda 2019, Top 10 Pipelines To Watch, Value Of Pharmaceuticals, and more!

Subscribe

Ad Right Bottom